Top Harvest Capital

Youlify offers AI solutions for medical billing, denied claims investigation, and real-time financial insights.

Voxel51, Inc., founded in 2016 and based in Ann Arbor, Michigan, specializes in computer vision and machine learning analytics for video and image understanding. The company develops AI software that transforms raw video footage and images into actionable intelligence, facilitating the exploration, visualization, curation, and testing of datasets alongside machine learning models. Voxel51's technology employs machine learning to process video content, providing simple image recognition and an understanding of motions and objects over time. This empowers computer vision data scientists to efficiently curate and experiment with their datasets, ultimately enhancing the performance of their machine learning systems.

Leash Biosciences engages in machine learning to solve medicinal chemistry.

Bioptimus specializes in the development of a universal artificial intelligence foundation model aimed at enhancing scientific research and biotechnological innovation. The company's technology seamlessly connects various scales of biology, ranging from molecules to cells, tissues, and entire organisms. By transforming multiscale data into actionable representations, Bioptimus enables its clients to drive breakthrough discoveries and accelerate advancements in the biomedical field.

Vectara is a provider of a generative AI product platform that enables the integration of advanced AI features into various applications. Its offering includes a serverless Retrieval Augmented Generation (RAG) API platform designed to embed generative AI functionality into chatbots and other products, relying on a robust hybrid-search core. This platform ensures accurate and contextually relevant responses, addressing critical challenges for enterprise adoption such as reducing hallucination, enhancing explainability, enforcing access control, and allowing real-time updates of knowledge. Vectara's technology also emphasizes data security and supports multilingual capabilities, making it suitable for a broad range of applications including conversational AI, question-answering, and semantic search. Through its innovative platform, Vectara helps businesses create effective AI-driven experiences while maintaining compliance with intellectual property and bias considerations.

Inato is a company focused on transforming the clinical trial process for life science organizations. Founded in 2016 and headquartered in Paris, with additional offices in New York and London, Inato provides an AI-powered platform that automates data collection and analysis for clinical trials. This platform enables pharmaceutical companies to significantly reduce drug development costs and expedite the launch of new therapies. Inato operates a global clinical trial marketplace that connects pharmaceutical companies with a diverse array of community research sites, promoting inclusivity and efficiency in clinical research. The company emphasizes collaborative enrollment planning and offers ongoing support to ensure successful trial delivery, ultimately helping to bring therapies to patients more quickly and affordably.

Asaren manages the mental health needs of their blue-chip clients' employees, with industries ranging from banking, energy, retail, and many others. They provide triage assessment, DNA testing, and online consultation with medical professionals.

Rembrand is an advertising agency that specializes in a range of marketing services, including brand strategy, campaign management, and social media marketing. The agency focuses on online marketing techniques such as content marketing, display advertising, and newsletter campaigns. Additionally, Rembrand offers services for brand creation, revitalization, design, and experience, as well as employer branding and search engine marketing. In a notable development, Rembrand has also developed a programmatic product placement platform that utilizes generative AI to enhance videos with virtual product placements. This innovative approach allows brands to connect with creators, making virtual placements more scalable and effective in monetizing video content without relying on interruptive ads.

Vectara is a provider of a generative AI product platform that enables the integration of advanced AI features into various applications. Its offering includes a serverless Retrieval Augmented Generation (RAG) API platform designed to embed generative AI functionality into chatbots and other products, relying on a robust hybrid-search core. This platform ensures accurate and contextually relevant responses, addressing critical challenges for enterprise adoption such as reducing hallucination, enhancing explainability, enforcing access control, and allowing real-time updates of knowledge. Vectara's technology also emphasizes data security and supports multilingual capabilities, making it suitable for a broad range of applications including conversational AI, question-answering, and semantic search. Through its innovative platform, Vectara helps businesses create effective AI-driven experiences while maintaining compliance with intellectual property and bias considerations.

Voxel51, Inc., founded in 2016 and based in Ann Arbor, Michigan, specializes in computer vision and machine learning analytics for video and image understanding. The company develops AI software that transforms raw video footage and images into actionable intelligence, facilitating the exploration, visualization, curation, and testing of datasets alongside machine learning models. Voxel51's technology employs machine learning to process video content, providing simple image recognition and an understanding of motions and objects over time. This empowers computer vision data scientists to efficiently curate and experiment with their datasets, ultimately enhancing the performance of their machine learning systems.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

Kinetix, founded in 2020 and based in Paris, France, specializes in empowering self-expression in the Metaverse through artificial intelligence and no-code tools. The company enables users to create 3D animations easily, making technology accessible to a wider audience. Kinetix operates at the intersection of 3D animation, gaming, and artificial intelligence, focusing on innovative solutions that allow individuals to express their creativity in virtual environments.

Mindmesh develops a knowledge base tool aimed at helping product-oriented teams and product managers address issues related to context switching and information fragmentation. The tool features an innovative interface that centralizes actionable items from notes, tasks, and calendars, integrating seamlessly with existing company tools such as Slack, Gmail, Calendar, Jira, and Drive. By facilitating the creation of bite-sized documentation and enabling efficient searches for scattered knowledge, Mindmesh fosters improved collaboration among employees, allowing team members to connect and share information regardless of their current tasks or locations.

MEDiC is a biotechnology company based in the San Francisco Bay Area that specializes in cancer drug discovery. It utilizes a proprietary CRISPR functional genomics platform to develop synergistic drug combinations aimed at treating tumors. The platform is designed to accurately capture tumor suppressor and oncogene phenotypes while systematically introducing CRISPR variants that replicate cancer mutations. This innovative approach allows MEDiC to measure the relationships between various drugs and a wide range of mutations, facilitating the development of targeted therapies to improve cancer treatment outcomes.

Mantium operates a secure cloud platform that facilitates the artificial intelligence journey for software developers through a no-code solution. The platform simplifies workflows by automating data preparation processes, allowing users to transform, clean, and enrich data from various sources. Mantium's services include the creation of copilots and plugins while managing data pipelines and infrastructure, ensuring data privacy and security throughout the process. This approach enables clients to effectively access and utilize large language models, making it easier for them to begin their AI initiatives.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.